TFFCX
Price
$76.48
Change
-$0.54 (-0.70%)
Updated
Jul 13 closing price
Net Assets
1.45B
VSTSX
Price
$354.42
Change
-$2.83 (-0.79%)
Updated
Jul 13 closing price
Net Assets
2.3T
Interact to see
Advertisement

TFFCX vs VSTSX

TFFCX vs VSTSX Comparison Chart in %
View a ticker or compare two or three
VS
TFFCX vs. VSTSX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TFFCX is a Buy and VSTSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VSTSX has more cash in the bank: 2.3T vs. TFFCX (1.45B). VSTSX pays higher dividends than TFFCX: VSTSX (1.07) vs TFFCX (0.00). TFFCX was incepted earlier than VSTSX: TFFCX (14 years) vs VSTSX (10 years). TFFCX (2.07) is less costly to investors than VSTSX (0.01). TFFCX is a more actively managed with annual turnover of: 6.00 vs. VSTSX (3.00). TFFCX has a lower initial minimum investment than VSTSX: TFFCX (2500) vs VSTSX (5000000000). VSTSX annual gain was more profitable for investors over the last year : 21.48 vs. TFFCX (10.26). VSTSX return over 5 years is better than : 66.56 vs. TFFCX (32.11).
TFFCXVSTSXTFFCX / VSTSX
Total Expense Ratio1.900.0119,000%
Annual Report Gross Expense Ratio2.070.0120,700%
Fund Existence14 years10 years-
Gain YTD5.42011.20548%
Front LoadN/AN/A-
Min. Initial Investment250050000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.45B2.3T0%
Annual Yield % from dividends0.001.07-
Returns for 1 year10.2621.4848%
Returns for 3 years41.5067.0662%
Returns for 5 years32.1166.5648%
Returns for 10 years105.89239.5344%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PWCIX95.22N/A
N/A
Principal Capital Appreciation Inst
PRLAX24.44N/A
N/A
T. Rowe Price Latin America
PACLX37.66N/A
N/A
T. Rowe Price Capital Appreciation Adv
RLIEX20.52N/A
N/A
Lazard International Equity R6
MCYIX16.37-0.51
-3.02%
NYLI Candriam Emerging Markets Eq Cl I